Showing results (61-70 of 144) with videos related to
Sort By:
Pageof 15
Expert Opinion on Pharmacotherapy|August 21, 2015
Real-world effectiveness of everolimus-based therapy versus endocrine monotherapy and chemotherapy in patients of HR+/HER2- breast cancer with liver metastasis in the USAPeggy L Lin, Yanni Hao, Jipan Xie, et al.Clinical Therapeutics|March 8, 2016
Effectiveness of Everolimus Versus Endocrine Monotherapy or Chemotherapy Among HR+/HER2- mBC Patients With Multiple Metastatic SitesNanxin Li, Yanni Hao, Jipan Xie, et al.Journal of Medical Economics|July 11, 2023
Economic and clinical burden of managing transfusion-dependent β-thalassemia in the United StatesChuka Udeze, Kristin A Evans, Yoojung Yang, et al.Current Medical Research and Opinion|December 15, 2015
Time on treatment of everolimus and chemotherapy among postmenopausal women with hormone-receptor-positive/human-epidermal-growth-factor-receptor-2-negative metastatic breast cancer: a retrospective claims study in the USNanxin Li, Yanni Hao, Andrew Kageleiry, et al.Journal of Medical Economics|April 9, 2026
Cost-effectiveness of exagamglogene autotemcel gene-edited therapy in patients with transfusion-dependent <b><i>β</i></b>-thalassemia in the United StatesChuka Udeze, Michael Gargano, Hongbo Yang, et al.Advances in Therapy|June 18, 2023
Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United StatesChuka Udeze, Kristin A Evans, Yoojung Yang, et al.Journal of Medical Economics|April 2, 2016
Comparison of medical costs and healthcare resource utilization of post-menopausal women with HR+/HER2- metastatic breast cancer receiving everolimus-based therapy or chemotherapy: a retrospective claims database analysisNanxin Li, Yanni Hao, Valerie Koo, et al.Research and Practice in Thrombosis and Haemostasis|February 4, 2021
Physical activity and bleeding outcomes among people with severe hemophilia on extended half-life or conventional recombinant factorsAnshu Shrestha, Jun Su, Nanxin Li, et al.Journal of Medical Economics|February 23, 2026
Cost-effectiveness of exagamglogene autotemcel gene-edited therapy in patients with sickle cell disease with recurrent vaso-occlusive crises in the United StatesAndrea Lopez, Michael Gargano, Hongbo Yang, et al.Food Chemistry|October 11, 2024
Visual colorimetric label for real-time monitoring of SO<sub>2</sub> concentration change in grape and mango during storageZiqiang Wang, Changxiang Hao, Nanxin Li, et al.Pageof 15